Combined Shareholders’ Meeting of 29 May 2020

This article or press release has no online content. Please download the associated documents for more information.

Associated Documents

Results-of-votes.pdf
Presentation-and-results-of-votes.pdf
PR-Post-Shareholders-Meeting-IPSEN-29-May-2020.pdf
Information-relating-to-the-Combined-Shareholders’-Meeting-of-29-May-2020.pdf
Convening-notice-and-Addendum.pdf
Voting-proxy-form.pdf
Shareholders-meeting-notice-published-at-the-BALO-on-11-May-2020-In-French-only.pdf
Shareholders-meeting-notice-published-at-the-BALO-on-11-May-2020-Translation-for-information.pdf

Understanding the true impact of living with FOP

Ipsen Announces Decision to Permanently Discontinue Distribution of NutropinAq® (somatropin) cartridges

Applications now open for the 2023 Golden Ticket Competition

Offering support to those impacted in Turkey & Syria

© Ipsen Pharma, 65 Quai Georges Gorse, 92100 Boulogne-Billancourt, France. All rights reserved - 2023